Evidence map›Paper›PMID 35054149›Full record

ReviewJournal of clinical medicine2022

Diagnosis of Mitral Valve Prolapse: Much More than Simple Prolapse. Multimodality Approach to Risk Stratification and Therapeutic Management.

Ali Alenazy, Abdalla Eltayeb, Muteb K Alotaibi, Muhammah Kashif Anwar, Norah Mulafikh, Mohammed Aladmawi, Olga Vriz

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Mitral and Tricuspid Valve Disease in Athletes.Journal of clinical medicine · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ali AlenazyHeart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.
Abdalla EltayebHeart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.
Muteb K AlotaibiRadiology Department, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.
Muhammah Kashif AnwarHeart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.
Norah MulafikhRadiology Department, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.
Mohammed AladmawiHeart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.
Olga VrizHeart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.
King Faisal Specialist Hospital & Research Centre · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral valve prolapse (MVP) is the most common valvular disease with a prevalence of 2%. It has generally a benign course; however, recent findings suggested an association between MVP and complex arrhythmias and eventually cardiac arrest and for this reason, it is also called arrhythmogenic MVP. Subjects who experience this complication are in general young women, with thickened mitral leaflets or bileaflet prolapse not necessarily associated with severe mitral regurgitation (MR). The nature of the relation between MVP and cardiac arrest is not clearly understood. Actually, the challenging task is to find the cluster of prognostic factors including T-wave inversion, polymorphic premature ventricular contractions, bileaflet prolapse, MR severity, but most importantly, those parameters of hypercontractility, mitral annulus disjunction (MAD), and myocardial fibrosis using a multimodality approach. Transthoracic echocardiography is the first-line imaging modality for the diagnosis of MVP, but also for detecting MAD and hypercontractility, followed by cardiac magnetic resonance for tissue characterization and detection of myocardial and papillary muscle fibrosis, using either late gadolinium enhancement (at the basal segment of the inferolateral wall and papillary muscles) (macro-fibrosis), or diffuse fibrosis by T1 mapping (native and post contrast T1). Moreover, there are also preliminary data on positron emission tomography utilizing

Indexed as

cardiac magnetic resonancecomplex ventricular arrhythmiasechocardiographymitral annulus disjunctionmitral valve prolapsemyocardial fibrosis

Identifiers

PMID35054149
PMCPMC8781541
OpenAlexW4206834875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.